Emulating Randomized Clinical Trials with Nonrandomized Real-World Evidence Studies: First Results from the RCT DUPLICATE Initiative

This paper report findings of first 10 trial emulations, evaluating CV outcomes of antidiabetic or antiplatelet medications. Interim findings indicate selection of active comparator therapies with similar indications and use patterns enhances validity of real-world evidence.

Source:

Circulation